Together these results demonstrate that STING pathway is involved in the transcriptional upregulation of type I IFNs triggered by genotoxic treatment of breast cancer cells, resulting in cell-autonomous activation of IFN/STAT1 signaling. This evidence concerns the gene IFNA1 and breast carcinoma.